![Jonathan Benjamin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jonathan Benjamin worked as a Medical Director-Clinical Research at Amgen, Inc. from 2014 to 2017.
He then worked as a Vice President-Clinical Research at Atreca, Inc. before becoming an Assistant Professor at Stanford University School of Medicine.
Benjamin holds a graduate and doctorate degree from New York University and an undergraduate degree from Harvard College.
Anciens postes connus de Jonathan Benjamin
Sociétés | Poste | Fin |
---|---|---|
ATRECA, INC. | Directeur Technique/Scientifique/R&D | 01/07/2020 |
AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/03/2017 |
Stanford University School of Medicine | Corporate Officer/Principal | - |
Formation de Jonathan Benjamin
Harvard College | Undergraduate Degree |
New York University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Atreca, Inc.
![]() Atreca, Inc. BiotechnologyHealth Technology Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA. | Health Technology |